G30-G32

Other degenerative diseases of the nervous system

The ICD-10-CM code block G30-G32, titled 'Other degenerative diseases of the nervous system,' comprises a group of progressive neurological conditions characterized by the systematic loss of neuronal structure and function. This section is clinically significant as it includes Alzheimer's disease (G30), which is the leading cause of dementia worldwide. Pathologically, these disorders are often classified as proteinopathies, involving the abnormal accumulation of proteins such as amyloid-beta, tau, and alpha-synuclein within the brain parenchyma. The block encompasses Alzheimer's disease in various forms, other specific degenerative conditions like Frontotemporal dementia (Pick's disease) and Lewy body dementia (G31), as well as neurodegenerative manifestations resulting from systemic diseases classified elsewhere (G32). These conditions are typically insidious in onset and follow a chronic, irreversible course leading to global cognitive decline, behavioral disturbances, and eventual loss of motor and autonomic control. Diagnostic workup involves a combination of neurocognitive testing, neuroimaging (MRI, PET), and sometimes cerebrospinal fluid analysis to identify specific biomarkers of neurodegeneration.

Clinical Symptoms

  • Progressive short-term memory loss (amnestic deficit)
  • Executive dysfunction including impaired planning and organization
  • Aphasia (difficulty with language production or comprehension)
  • Apraxia (inability to perform learned purposeful movements)
  • Agnosia (failure to recognize familiar objects or people)
  • Visual-spatial disturbances and disorientation to surroundings
  • Personality and behavioral changes (apathy, disinhibition, or irritability)
  • Anosognosia (lack of insight into one's own cognitive deficits)
  • Sundowning (increased confusion and agitation in the evening)
  • REM sleep behavior disorder
  • Hallucinations and delusions
  • Gait disturbances and postural instability
  • Bradykinesia and rigidity in advanced stages
  • Dysphagia (difficulty swallowing)
  • Myoclonus (involuntary muscle jerks)
  • Urinary and fecal incontinence

Common Causes

  • Genetic mutations in APP (Amyloid Precursor Protein)
  • Mutations in PSEN1 and PSEN2 (Presenilin) genes
  • Presence of the Apolipoprotein E (APOE) epsilon-4 allele
  • Pathological accumulation of extracellular amyloid-beta plaques
  • Formation of intracellular tau neurofibrillary tangles
  • Chronic neuroinflammation and microglial activation
  • Oxidative stress and mitochondrial dysfunction
  • Misfolding of alpha-synuclein or TDP-43 proteins
  • Advanced age (primary non-genetic risk factor)
  • Cerebrovascular disease and chronic cerebral hypoperfusion
  • Traumatic brain injury history
  • Metabolic syndromes including Type 2 diabetes and hypertension
  • Chronic nutritional deficiencies (e.g., Vitamin B12)
  • Paraneoplastic syndromes and systemic autoimmunity

Documentation & Coding Tips

Differentiate between early and late onset Alzheimer's disease for accurate clinical characterization.

Example: Patient diagnosed with Alzheimer's disease with late onset (G30.1) at age 78. Clinical progression shows progressive memory loss and executive dysfunction. This chronic condition maps to HCC 52, and the documentation of late onset versus early onset (before age 65) is required for ICD-10-CM specificity.

Billing Focus: The documentation must specify the age of onset to distinguish between G30.0 (early) and G30.1 (late).

Always document associated behavioral disturbances using the appropriate secondary dementia codes.

Example: A 82-year-old female with Alzheimer's disease with late onset (G30.1) exhibits frequent agitation and verbal aggression (F02.811). The inclusion of behavioral disturbance is essential for both clinical management and to reflect the increased complexity and resource intensity of the care provided.

Billing Focus: Requires two codes: the underlying degenerative disease (G30.1) followed by the manifestation code (F02.811).

Specify the type of frontotemporal dementia to differentiate between Pick's disease and other variants.

Example: The patient presents with Pick's disease (G31.01) characterized by marked personality changes and social inhibition. MRI shows circumscribed frontal and temporal lobe atrophy. Specifying G31.01 instead of G31.09 (other frontotemporal dementia) ensures the highest level of clinical specificity.

Billing Focus: Use G31.01 for Pick's disease and G31.09 for other types of frontotemporal dementia.

Clearly document Dementia with Lewy Bodies as the primary diagnosis when appropriate.

Example: Patient presents with visual hallucinations, REM sleep behavior disorder, and parkinsonism. Diagnosis confirmed as Dementia with Lewy Bodies (G31.83). Note the absence of a preceding Parkinson's disease diagnosis to distinguish from Parkinson's disease dementia.

Billing Focus: The code G31.83 includes both the Lewy body disease and the associated dementia; however, an additional code for the dementia manifestation is required for full specificity.

Document the specific etiology of degenerative nervous system disorders related to alcohol or other substances.

Example: Chronic neurological evaluation reveals degeneration of the nervous system due to alcohol (G31.2). Patient presents with cerebellar ataxia and peripheral neuropathy secondary to long-term alcohol use disorder. Documentation supports the causal link between substance use and neurological degeneration.

Billing Focus: G31.2 requires an additional code to identify the alcohol use, such as F10.2x for alcohol dependence.

Relevant CPT Codes

Related Diagnoses

Hierarchy